It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
Migraine is a common headache disorder, with cortical spreading depolarization (CSD) considered as the underlying electrophysiological event. CSD is a slowly propagating wave of neuronal and glial depolarization. Sleep disorders are well known risk factors for migraine chronification, and changes in wake-sleep pattern such as sleep deprivation are common migraine triggers. The underlying mechanisms are unknown. As a step towards developing an animal model to study this, we test whether sleep deprivation, a modifiable migraine trigger, enhances CSD susceptibility in rodent models.
Methods
Acute sleep deprivation was achieved using the “gentle handling method”, chosen to minimize stress and avoid confounding bias. Sleep deprivation was started with onset of light (diurnal lighting conditions), and assessment of CSD was performed at the end of a 6 h or 12 h sleep deprivation period. The effect of chronic sleep deprivation on CSD was assessed 6 weeks or 12 weeks after lesioning of the hypothalamic ventrolateral preoptic nucleus. All experiments were done in a blinded fashion with respect to sleep status. During 60 min of continuous topical KCl application, we assessed the total number of CSDs, the direct current shift amplitude and duration of the first CSD, the average and cumulative duration of all CSDs, propagation speed, and electrical CSD threshold.
Results
Acute sleep deprivation of 6 h (n = 17) or 12 h (n = 11) duration significantly increased CSD frequency compared to controls (17 ± 4 and 18 ± 2, respectively, vs. 14 ± 2 CSDs/hour in controls; p = 0.003 for both), whereas other electrophysiological properties of CSD were unchanged. Acute total sleep deprivation over 12 h but not over 6 h reduced the electrical threshold of CSD compared to controls (p = 0.037 and p = 0.095, respectively). Chronic partial sleep deprivation in contrast did not affect CSD susceptibility in rats.
Conclusions
Acute but not chronic sleep deprivation enhances CSD susceptibility in rodents, possibly underlying its negative impact as a migraine trigger and exacerbating factor. Our findings underscore the importance of CSD as a therapeutic target in migraine and suggest that headache management should identify and treat associated sleep disorders.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Massachusetts General Hospital, Harvard Medical School, Neurovascular Research Laboratory, Department of Radiology, Charlestown, USA; Sapienza University of Rome, Department of Clinical and Molecular Medicine, Rome, Italy (GRID:grid.7841.a)
2 Massachusetts General Hospital, Harvard Medical School, Neurovascular Research Laboratory, Department of Radiology, Charlestown, USA (GRID:grid.7841.a)
3 Harvard Medical School, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
4 Boston Children’s Hospital, Department of Pathology, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438)
5 Massachusetts General Hospital, Harvard Medical School, Neurovascular Research Laboratory, Department of Radiology, Charlestown, USA (GRID:grid.2515.3); Massachusetts General Hospital, Harvard Medical School, Stroke Service and Neuroscience Intensive Care Unit, Department of Neurology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
6 Sapienza University of Rome, Department of Clinical and Molecular Medicine, Rome, Italy (GRID:grid.7841.a)
7 Massachusetts General Hospital, Harvard Medical School, Department of Radiology, and Department of Neurology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
8 Massachusetts General Hospital, Harvard Medical School, Neurovascular Research Laboratory, Department of Radiology, Charlestown, USA (GRID:grid.32224.35); Massachusetts General Hospital, Harvard Medical School, Department of Radiology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)